메뉴 건너뛰기




Volumn 18, Issue 8, 2014, Pages 899-904

Mass treatment to eliminate tuberculosis from an island population

Author keywords

Mass treatment; tuberculosis; elimination

Indexed keywords

TUBERCULOSTATIC AGENT;

EID: 84904579332     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.14.0007     Document Type: Article
Times cited : (10)

References (17)
  • 2
    • 42549162084 scopus 로고    scopus 로고
    • Eliminating human tuberculosis in the twenty-first century
    • DOI 10.1098/rsif.2007.1138, PII N502JJ12W45R6403
    • Dye C, Williams B G. Eliminating human tuberculosis in the twenty-first century. J R Soc Interface 2008; 5: 653-662. (Pubitemid 351589747)
    • (2008) Journal of the Royal Society Interface , vol.5 , Issue.23 , pp. 653-662
    • Dye, C.1    Williams, B.G.2
  • 5
    • 0014095263 scopus 로고
    • A controlled trial of community-wide isoniazid prophylaxis in Alaska
    • Comstock G W, Ferebee S H, Hammes L M. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 1967; 95: 935-943.
    • (1967) Am Rev Respir Dis , vol.95 , pp. 935-943
    • Comstock, G.W.1    Ferebee, S.H.2    Hammes, L.M.3
  • 6
    • 0015428195 scopus 로고
    • Preventive treatment of untreated, nonactive tuberculosis in an Eskimo population
    • Comstock G W, Woolpert S F. Preventive treatment of untreated, nonactive tuberculosis in an Eskimo population. Arch Environ Health 1972; 25: 333-337.
    • (1972) Arch Environ Health , vol.25 , pp. 333-337
    • Comstock, G.W.1    Woolpert, S.F.2
  • 7
    • 0018760256 scopus 로고
    • Isoniazid prophylaxis among Alaskan Eskimos: A final report of the Bethel isoniazid studies
    • Comstock G W, Baum C, Snider D E, Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies. Am Rev Respir Dis 1979; 119: 827-830.
    • (1979) Am Rev Respir Dis , vol.119 , pp. 827-830
    • Comstock, G.W.1    Baum, C.2    Snider Jr., D.E.3
  • 8
    • 0014635275 scopus 로고
    • Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area
    • Horwitz O, Wilbek E, Erickson P A. Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. Bull World Health Organ 1969; 41: 95-113.
    • (1969) Bull World Health Organ , vol.41 , pp. 95-113
    • Horwitz, O.1    Wilbek, E.2    Erickson, P.A.3
  • 9
    • 18844479969 scopus 로고    scopus 로고
    • Population screening and mass chemoprophylaxis in Kiribati
    • Daulako E C. Population screening and mass chemoprophylaxis in Kiribati. Int J Lepr Other Mycobact Dis 1999; 67 (Suppl): S23-S25.
    • (1999) Int J Lepr Other Mycobact Dis , vol.67 , Issue.SUPPL.
    • Daulako, E.C.1
  • 10
    • 83155182847 scopus 로고    scopus 로고
    • Three months of rifapentine and isoniazid for latent tuberculosis infection
    • Sterling T R, Villarino ME, Borisov A S, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365: 2155-2166.
    • (2011) N Engl J Med , vol.365 , pp. 2155-2166
    • Sterling, T.R.1    Villarino, M.E.2    Borisov, A.S.3
  • 11
    • 84921430332 scopus 로고    scopus 로고
    • Regimens of less than six months for treating tuberculosis
    • Gelband H. Regimens of less than six months for treating tuberculosis. Cochrane Database Syst Rev 2000; (2): CD001362.
    • (2000) Cochrane Database Syst Rev , Issue.2
    • Gelband, H.1
  • 12
    • 84863584732 scopus 로고    scopus 로고
    • New drugs for the treatment of tuberculosis: Hope and reality
    • Grosset J H, Singer T G, Bishai W R. New drugs for the treatment of tuberculosis: hope and reality. Int J Tuberc Lung Dis 2012; 16: 1005-1014.
    • (2012) Int J Tuberc Lung Dis , vol.16 , pp. 1005-1014
    • Grosset, J.H.1    Singer, T.G.2    Bishai, W.R.3
  • 13
    • 34548678627 scopus 로고    scopus 로고
    • Asymptomatic hepatotoxicity in patients treated for tuberculosis and latent tuberculosis
    • DOI 10.1097/IPC.0b013e3181373d3a, PII 0001904820070900000006
    • Schlossberg D, Pritchett N, Nnumolu C. Asymptomatic hepatotoxicity in patients treated for tuberculosis and latent tuberculosis. Infect Dis Clin Pract 2007; 15: 320-323. (Pubitemid 47415196)
    • (2007) Infectious Diseases in Clinical Practice , vol.15 , Issue.5 , pp. 320-323
    • Schlossberg, D.1    Pritchett, E.N.2    Nnumolu, C.3
  • 15
    • 0029781041 scopus 로고    scopus 로고
    • Liver injury during antituberculosis treatment: An 11-year study
    • DOI 10.1016/S0962-8479(96)90098-2
    • Dossing M, Wilcke J T, Askgaard D S, Nybo B. Liver injury during antituberculosis treatment: an 11-year study. Tubercle Lung Dis 1996; 77: 335-340. (Pubitemid 26258538)
    • (1996) Tubercle and Lung Disease , vol.77 , Issue.4 , pp. 335-340
    • Dossing, M.1    Wilcke, J.T.R.2    Askgaard, D.S.3    Nybo, B.4
  • 16
    • 39449127844 scopus 로고    scopus 로고
    • Nuffield Council on Bioethics London, UK: Nuffield Council on Bioethics Accessed May 2014
    • Nuffield Council on Bioethics. Public health: ethical issues. London, UK: Nuffield Council on Bioethics, 2007. http://www.nuffieldbioethics.org/public- health. Accessed May 2014.
    • (2007) Public Health: Ethical Issues


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.